United States: An Oddity: Approval And Regulatory Authority Over Cosmetics

For various reasons, we are seeing a growth of lawsuits alleging injuries from use of overthe- counter cosmetics sprouting up across the country.1 Social media reflects the invasion of the "safe beauty products" movement. For example, we are urged to trash the face lotion sitting on our bathroom counters because it is "toxic" to our well-being and to replace it with the promoter's product because it is "better" for us. Cosmetic industry news is all the buzz regarding regulatory authority over cosmetics.2


Fundamental to any discussion regarding cosmetics claims is the significant legal distinction between "cosmetics" and "drugs." In order to differentiate ownership of regulatory authority over cosmetic products, we must first recognize which products qualify as cosmetics and why they are not categorized as drugs. I am not sure about you, but when I see or hear the word "cosmetics," I think of makeup. I think of all of the products found on "that aisle" of my neighborhood supermarket. I do not think of "cosmetics" as drugs. This assumption is fairly accurate, and to the ordinary consumer it means little. But to those of us in the cosmetic or drug industry, the differences between cosmetics and drugs demand a multitude of considerations.

The Food and Drug Administration (FDA) provides that products intended to cleanse or beautify are generally regulated as cosmetics.3 "Articles intended to be rubbed, poured, sprinkled, or sprayed on, introduced into, or otherwise applied to the human body...for cleansing, beautifying, promoting attractiveness, or altering the appearance" are cosmetics.4 Such articles include many items that you would expect to be a cosmetic, like lipsticks, fingernail polishes, eye shadows, and blushes, but also include moisturizing lotions, perfumes, shampoos, hair coloring products, and deodorants, plus "any substance intended for use as a component of a cosmetic product."5


By contrast, products such as acne treatments, sunscreens, antiperspirants, and ointments, intended to treat or prevent disease, or affect the structure or function of the body, are drugs.6 Even if these products affected how you look, they are still considered drugs.7 Manufacturers likely prefer the less cumbersome regulations applicable to cosmetics and do not want their product to be construed as a drug. But cosmetic safety becomes an issue. If the safety of a cosmetic is not adequately substantiated, the product may be considered misbranded and may be subject to regulatory action, unless the label provides the following statement: Warning—The safety of this product has not been determined.8

This is where the confusion sets in. Cosmetics and drugs are two separate categories of products and must adhere to different laws and regulations. The difference is in how the law defines their intended use.9 Some products are both cosmetics and drugs.10 If this occurs, those products must meet the requirements for both cosmetics and drugs.11 Examples include antidandruff shampoos (which cleanse the hair and treat dandruff) and antiperspirant-deodorants, as well as moisturizers and makeup with SPF (sun protection factor) numbers.12


Intended use is the basis by which a product is defined as either a cosmetic or drug. But how is a product's intended use established? Claims stated on promotional materials (e.g. product labeling, advertising) may affect the categorization of a product13 (discussed in detail below). Even if a product is marketed as a cosmetic, certain marketing statements may otherwise characterize the product as a drug.14 For example, a daily facial moisturizer that promises to decrease the production of pigment in the skin, although marketed as a cosmetic, would be considered a drug.15

Consumer perception is another way that intended use is established.16 The product's reputation may play a role in classification. The reason the consumer is purchasing the product and the use for which it is purchased are factors to be considered.17 Probably the most relatable example of intended use is the functionality of the ingredients.18 If there is a well-known therapeutic use for the product, then it would be considered a drug. Examples include fluoride in toothpaste and aromatherapy (sleep aid) in essential oils.19

With this better understanding of why certain products are termed cosmetics, we turn to the regulatory implications associated with cosmetics that some love and others appear to hate.

Cosmetic products are regulated by the FDA pursuant to the Federal Food, Drug, and Cosmetic Act (FDCA), which is codified into Title 21 Chapter 9 of the United States Code. "FDA enforces laws enacted by Congress and issues regulations as authorized by Congress to implement its statutory authority. The regulations can create binding obligations and have the force of law."20 While the FDCA establishes that the FDA has authority over product safety, unlike most drugs, cosmetic products and their ingredients, with the exception of color additives, do not have to undergo premarket FDA review or approval.21

Good Manufacturing Practice (GMP) is a tool to help assure cosmetic products are neither adulterated nor misbranded, and manufacturers are responsible for compliance.22 While the FDA has provided recommendations for cosmetic GMP, there are no regulations setting forth particular GMP requirements for cosmetics.23 In contrast, strict adherence to GMP requirements for drugs is mandatory.24 Selling "adulterated" or "misbranded" cosmetics is prohibited by the FDCA. Penalties can be imposed for doing so.25 Cosmetics become "adulterated" if the product's composition is compromised with violations involving ingredients, contaminants, processing, packaging, or shipping and handling.26 Cosmetics are "misbranded" if the violations involve improper labeling or deceptively packaged products.27 If a cosmetic label is false or misleading or fails to provide required information, it is considered misbranded.28 Even if the label provides the required information, the label can become misbranded if it is improperly displayed.29

Registration is another procedure that brings about different legal and regulatory propositions in the cosmetic world. While drug makers are required to register their foreign and domestic establishments with the FDA,30 "[U]nder the law, manufacturers are not required to register their cosmetic establishments or file their product formulations with FDA, and no registration number is required to import cosmetics into the United States."31 However, the Voluntary Cosmetic Registration Program (VCRP) for cosmetic establishments and formulations32 is maintained by the FDA and participation is encouraged.33



Labeling and misbranding issues are the impetus for many cosmetics lawsuits. Let us dissect what labeling means before authoritative power is discussed. Any label or other written, printed, or graphic matter on or accompanying a product constitutes labeling.34 The principal display panel and information panel, which have their own informational requirements, are also considered parts of the label and accommodate label information.35

The cosmetics marketed and distributed in the United States, no matter where they are manufactured, must comply with the labeling regulations published by the FDA under the authority of the FDCA and the Fair Packaging and Labeling Act (FPLA).36 These laws and associated regulations are "intended to protect consumers from health hazards and deceptive practices and to help consumers make informed decisions regarding product purchase."37 For cosmetics marketed on a retail basis to consumers, FDA requires a declaration of ingredients on the product label.38 Under the FDCA, cosmetics that fail to comply with the FPLA are considered misbranded.39 Likewise, if the labeling is "false or misleading in any particular," then it is prohibited.40 However, the FDA does not have authority to approve cosmetic product labeling before it hits the market.

The authority of the Federal Trade Commission (FTC) also comes into play. Pursuant to the Federal Trade Commission Act (FTCA), the FTC is given the authority to prevent unfair or deceptive acts or practices in or affecting commerce. An "unfair or deceptive act or practice" under the FTCA includes "the dissemination or the causing to be disseminated of any false advertisement."41 Arguably, to the ordinary consumer it is easy to confuse the responsibilities and governance of the FTC and FDA, because labeling and advertising appear to fall under the same umbrella of "marketing." But authority over labeling and advertising is different, and it is apparent in the FTCA's definition of "false advertisement." A false advertisement is "an advertisement, other than labeling, which is misleading in a material respect."42 Although the FDA and FTC work to eliminate misleading elements associated with cosmetics, each has a specific authority – the FDA regulates labeling and the FTC regulates advertising. Courts have recognized this limitation of the FTCA's reach.43


In addition, the FTC and FDA entered into a Memorandum of Understanding that makes clear that cosmetic labeling is excluded from the items that fall under the scope of the FTC's regulatory authority. The Memorandum provides that the FTC "has primary responsibility with respect to the regulation of the truth or falsity of all advertising (other than labeling) of foods, drugs, devices and cosmetics."44 This Memorandum remains in effect today, and it further establishes that cosmetics labeling is a matter for the FDA.

If the FDA does not and cannot pre-approve cosmetic product labeling, it is improper to label cosmetics "FDA Approved." Cosmetic labeling or advertising containing language that suggests that the FDA has approved the product is prohibited. Even if the product is on file with FDA's VCRP,45 the same restriction applies. As such, a false or misleading statement on labeling renders a cosmetic "misbranded."


We have established that cosmetics do not undergo pre-market FDA review or approval. The FDA does not approve cosmetic product labeling, so proper labeling lies in the hands of the cosmetic manufacturer's and/or distributor's hands. Cosmetic manufacturers or companies and individuals who market cosmetics are legally responsible for ensuring that their products are safe. Safety tests for the individual products and/or their ingredients are not required under the law or under FDA regulations.46

So, how does the FDA assist in assuring cosmetic safety to the consumer? Although the FDA does not require these companies to test their products' safety, it has consistently encouraged them to do so. Manufacturers and marketers run the risk of having their products deemed adulterated or misbranded if they are not marketed appropriately, which could in turn subject them to regulatory action.47

If the FDA has reliable information that a cosmetic is adulterated or misbranded, the FDA can file an action through the Department of Justice in federal court to have the cosmetic removed from the market.48 Likewise, to ensure that further shipments of that product do not continue, the FDA may request the issuance of a restraining order.49 Further, if the manufacturer or individual is violating the law, the government may seize the property or the FDA can initiate criminal action.50

Cosmetic manufacturing facilities are subject to inspections, and discovery of non-compliance with the FDCA and FPLA can occur through inspections. The FDA can and does inspect and even collects samples for examination and analysis to assure cosmetic safety.51 The FDA will also inspect in response to cosmetic adverse event complaints.52 While the FDA is not authorized to recall adulterated or misbranded cosmetics, it does have the ability to monitor companies that issue recalls on their own initiative. Either that, or the FDA can request a recall if the company is unwilling to remove the product at issue without the FDA's written request.53

Another measure of safety assurance implemented by the FDA involves overseeing imports. U.S. Customs and Border Protection works with the FDA to monitor imports. Imported cosmetics are subject to review by FDA at the time of entry through U.S. Customs under section 801(a) of the FDCA.54 If the products are noncompliant, it is possible they will not be permitted into the United States.55 If the products are not brought into compliance, they will either be destroyed or sent back.56 Even if the cosmetics are not inspected upon entry, every shipment of cosmetics that enters the United States is subject to the laws the FDA enforces.57


For cosmetic manufacturers, it appears at first blush that the less stringent legal and regulatory requirements qualifying a product as a cosmetic would be most appealing. However, as discussed above, there is a unique set of factors that a manufacturer must take into consideration if hoping to market a product as a cosmetic. Ensuring that the product does not cross the faint line that distinguishes it as a drug is of utmost importance. Misbranding of products remains of grave concern amongst the cosmetic and drug industries. The FDA is working within its regulatory authority over cosmetic product labeling, but the fact remains that its limited control in this arena is the talk (and worry) of the town. The "safe beauty product" movement that implicates regulatory and approval authority over cosmetics is the real deal, and it does not appear to be going away anytime soon.


1 See Morales v. Conopco, Inc., No. 2:13-2213 WBS EFB, 2016 WL 3688407 (E.D. Cal. July 12, 2016) (where Plaintiffs filed suit due to alleged misleading nature of certain hair care products being labeled "TRESemme Naturals" despite the products containing synthetic ingredients); see also Michael v. Honest Company, Inc., No. LACV1507059JAKAGRX, 2016 WL 8902574 (C.A. Cal. Dec. 6, 2016) (class-action lawsuit over claims that a number of defendant's "Natural Products" contain non-natural ingredients).

2 Laura Entis, That Moisturizer You're Slathering on Your Face Isn't Regulated, Fortune (June 27, 2017), http://fortune.com/2017/06/27/fda-cosmetics-regulations/; Jane Brody, For Cosmetics, Let the Buyer Beware, New York Times (Aug. 7, 2017), https://www.nytimes.com/2017/08/07/well/for-cosmetics-let-the-buyer-beware.html.

3 Cosmetics Safety Q&A: Personal Care Products, U.S. Food & Drug Administration (Feb. 22, 2018), https://www.fda.gov/cosmetics/resourcesforyou/consumers/ucm136560.htm.

4 21 U.S.C.A. § 321(i) (2012).

5 Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?), U.S. Food & Drug Administration (Mar. 6, 2018), https://www.fda.gov/Cosmetics/GuidanceRegulation/LawsRegulations/ucm074201.htm.

6 Cosmetics Safety Q&A: Personal Care Products, supra note 3.

7 Id.

8 See 21 C.F.R. § 740.10 (2018).

9 Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?), supra note 5.

10 The FDCA does not recognize any such category as "cosmeceuticals." See Id.

11 Id.

12 Id.

13 Id.

14 Id.

15 Id.

16 Id.

17 Id.

18 Id.

19 Id.

20 Guidance & Regulation, U.S. Food & Drug Administration (Nov. 3, 2017), https://www.fda.gov/Cosmetics/GuidanceRegulation/default.htm.

21 Is It a Cosmetic, a Drug, or Both? (Or Is It Soap?), supra note 5.

22 Id.

23 Id.

24 Id.

25 See 21 U.S.C. §§ 331(a), 361-62(a)-(d).

26 FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated, U.S. Food & Drug Administration (Nov. 3, 2017), https://www.fda.gov/cosmetics/guidanceregulation/lawsregulations/ucm074162.htm.

27 Id.

28 Id.

29 Id.

30 See 21 C.F.R. § 207 (2018).

31 FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated, supra note 26.

32 See 21 C.F.R. §§ 710, 720 (2018).

33 FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated, supra note 26.

34 21 U.S.C. § 321(m).

35 Labeling Regulations, U.S. Food & Drug Administration (Mar. 6, 2018), https://www.fda.gov/Cosmetics/Labeling/Regulations/default.htm.

36 Id.

37 Id.

38 FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated, supra note 26.

39 See Id. (noting that cosmetics distributed solely for professional use, institutional use, or as free samples or hotel amenities are not included).

40 Id.

41 See 15 U.S.C. § 52.

42 15 U.S.C. § 55(a)(1).

43 See, e.g., F.T.C. v. Pantron I Corp., 33 F.3d 1088, 1095 (9th Cir. 1994) (recognizing that the FTCA defines "false advertisement" as an advertisement, other than labeling ...); see also Miles Labs., Inc. v. FTC, 50 F. Supp. 434, 437 (D.D.C. 1943) ("The dissemination of a 'false advertisement' by a corporation otherwise than on the labels carried by its products is an unfair or deceptive act or practice which is declared unlawful and which the Federal Trade Commission is empowered and directed to prevent.") (emphasis added), aff'd, 140 F.2d 683 (D.C. Cir. 1944).

44 Memorandum of Understanding Between Federal Trade Commission and the Food and Drug Administration, 36 Fed, Reg. 18539-02 (Sept. 16, 1971).

45 See 21 C.F.R. §§ 710.8, 720.9 (providing that participation in the VCRP to suggest official approval is prohibited).

46 FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated, supra note 26.

47 See Estee Lauder, Inc. v. U.S. Food & Drug Admin., 727 F. Supp.1 (D.D.C. 1989) (regulatory letter written to cosmetic manufacturer about its anti-aging claims on skin cream labeling that allegedly presented to affect the structure or function of the body and warned that the administration was prepared to invoke sanctions such as seizures and injunctions pursuant to the FDCA); see also Mollicone v. Universal Handicraft, Inc. et al., No. 216CV07322CASMRWX, 2017 WL 440257, (C.D. Cal. Jan. 30, 2017) (where Plaintiff alleged violations of the FDCA based on allegations that the products are misbranded - products neither "halt the aging process" nor are they "proven to restore youthful appearance" - and are unlawfully sold as unapproved drugs). 48. FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated, supra note 26.

49 Id.

50 Id.

51 See United States v. Roux Labs., Inc., 456 F. Supp. 973 (M.D. Fla. 1978) (imposition of sanctions considered where defendant resisted compliance with warrant for FDA to inspect defendant laboratories and collect samples of materials used in hair dye products).

52 See Statement on FDA Investigation of WEN by Chaz Dean Cleansing Conditioners, U.S. Food & Drug Administration (Nov. 15. 2017), https://www.fda.gov/cosmetics/productsingredients/products/ucm511626.htm. (reporting that these conditioners resulted in hair loss, hair breakage, balding, itching and rash).

53 FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated, supra note 26.

54 Id.

55 Id.

56 Id.

57 Id.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Mondaq Free Registration
Gain access to Mondaq global archive of over 375,000 articles covering 200 countries with a personalised News Alert and automatic login on this device.
Mondaq News Alert (some suggested topics and region)
Select Topics
Registration (please scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions